Top Story

REDUCE-HTN: REINFORCE study of renal denervation system underway

REDUCE-HTN: REINFORCE study of renal denervation system underway
April 18, 2015

Boston Scientific has begun enrollment of the REDUCE-HTN: REINFORCE study, which will evaluate the efficacy and safety of renal denervation in patients with hypertension, according to a press release.

The randomized, sham-controlled, multicenter study will assess the Vessix Renal Denervation System in 100 patients.

VIDEO: SAPIEN 3 valve yields low mortality, stroke rates in high, intermediate-risk patients Meeting News CoverageVideo

VIDEO: SAPIEN 3 valve yields low mortality, stroke rates in high, intermediate-risk patients

April 17, 2015
SAN DIEGO — In this video, Susheel Kodali, MD, of Columbia University Medical Center, New York-Presbyterian Hospital, discusses the 30-day results from the SAPIEN…
In the Journals

More adolescents with elevated LDLs would receive statins under adult treatment guidelines

April 17, 2015
Applying pediatric treatment guidelines for elevated low density lipoprotein cholesterol levels in young adults could result in a six-fold increase in the use of statin…
FDA News

FDA approves new generation of single-lead ICDs

April 17, 2015
Biotronik announced that it has received FDA approval for the company’s most recent generation of implantable cardioverter defibrillators. The approval was for the…
Lloyd Klein In the Journals

Risk for work-related injuries persists among interventional cardiologists

April 17, 2015
Work-related orthopedic injuries were reported by half of interventional cardiologists who responding to a survey conducted by the Society for Cardiovascular Angiography…
More News Headlines »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
Meeting News Coverage Video
VIDEO: Emerging interventional heart failure therapies improve patient care

VIDEO: Emerging interventional heart failure therapies improve patient care

April 17, 2015
SAN DIEGO — William T. Abraham, MD, director of the division of cardiovascular medicine at The Ohio…
More »
CME
Best of Lipid Forum III

Best of Lipid Forum III

This activity is supported by an educational grant from Amgen, Inc.

Appropriate therapies for various dyslipidemias remain a challenge for practitioners struggling to reduce residual risk…
More »
morganatic-roan
morganatic-roan